Why Definitive Healthcare Corp.’s (DH) Stock Is Down 5.17%
As of Friday, July 31, Definitive Healthcare Corp.’s DH share price has dipped by 5.17%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Commentary & Analysis
Why Definitive Healthcare Corp.’s (DH) Stock Is Up 5.12%
As of Tuesday, July 28, Definitive Healthcare Corp.’s DH share price has surged by 5.12%, which has investors questioning if this is right time to sell.Michael Rose
Why Definitive Healthcare Corp.’s (DH) Stock Is Down 5.97%
As of Monday, July 20, Definitive Healthcare Corp.’s DH share price has dipped by 5.97%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Definitive Healthcare Corp.’s (DH) Stock Is Up 6.01%
As of Friday, July 10, Definitive Healthcare Corp.’s DH share price has surged by 6.01%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Definitive Healthcare Corp.’s (DH) Stock Is Down 5.40%
As of Wednesday, July 08, Definitive Healthcare Corp.’s DH share price has dipped by 5.40%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | DH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $72.0 | $179.6 | 19% |
|
| Shares Out (Mil) | 104.7 | 47.9 | 63% |
|
| Institutional Ownership | 80.3% | 78.6% | 49% |
|
| Float (Mil) | 36.0 | 40.1 | 40% |
|
| Beta | 1.33 | 1.22 | 77% |
|
| Avg Daily Volume (000s) | 150 | 205 | 41% |
|
| Price Change (52-week) |
(82.9%) | 41.0% | 6% |
|
| Growth | DH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.3% | 13.7% | 74% |
|
| Net Income (5yr) | (21.4%) | (1.0%) | 19% |
|
| EPS (5yr) | na | 15.5% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 33.4% | (15.5%) | 88% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 7 | |
| Current EPS | $0.043 | $0.185 | $0.186 | |
| Month Ago EPS | $0.042 | $0.185 | $0.185 | |
| # Rev Up | 1 | 0 | 2 | |
| # Rev Down | 0 | 4 | 0 | |
| Three Months Ago EPS | $0.042 | $0.167 | $0.190 | |
| Year/Year Chg | (103.2%) | (114.2%) | (118.4%) | |
| Financials | DH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $238 | $192 | 34% |
|
| Net Income (TTM) (Mil) | ($170) | ($9) | 7% |
|
| EPS (TTM) | ($1.628) | ($0.500) | 17% |
|
| Operating Cash Flow (TTM) (Mil) | $39 | $8 | 45% |
|
| Net Cash Flow (TTM) (Mil) | $52 | ($3) | 71% |
|
| Long-Term Debt (Q1) (Mil) | $158 | $14 | 48% |
|
| Enterprise Value (Q1) (Mil) | $121 | $215 | 23% |
|
| Valuation | DH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.49 | 1.22 | 8% |
|
| P/E | na | 36.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | DH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 84.4% | 61.6% | 91% |
|
| Net Margin | (71.5%) | (29.3%) | 9% |
|
| ROA | (25.7%) | (21.9%) | 18% |
|
| ROE | (72.6%) | (1.4%) | 12% |
|
| Liabilities to Assets | 63.0% | 33.3% | 57% |
|
| F-Score | 7 | 4 | 84% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Price-to-Free-Cash-Flow Screen
Factors: Value
An exploration of the basics of cash flow analysis and the implementation of a price-to-free-cash-flow screen.
| Performance Since Inception: | 16.7% |
| +/- S&P 500: | +9.2 |
